- Global Pharma News & Resources

PotentiaMetrics and Ascend Collaborate to Launch Disruptive Cancer Outcomes Platform

PotentiaMetrics and Ascend Collaborate to Launch Disruptive Cancer Outcomes Platform MyCancerJourney empowers patients with actionable information to improve the patient experience, improve outcomes while saving millions of dollars for patients and self-insured employers.

PR Newswire

AUSTIN, Texas, Sept. 27, 2018

AUSTIN, Texas, Sept. 27, 2018 /PRNewswire-PRWeb/ -- PotentiaMetrics announced today that it has partnered with AscendPBM to launch MyCancerJourney, a shared decision-making platform for cancer patients specifically designed to provide high quality care while reducing the overall cost of treatment.

Research presented at the most recent meeting of the American Society of Clinical Oncology suggest that in some cases less treatment leads to better health outcomes for patients, and a 2012 National Academies report found that 30% of healthcare spending was wasted.

MyCancerJourney was developed with researchers at Washington University School of Medicine in St. Louis to provide real world information to patients and their healthcare providers on treatment decisions that provide the most benefit as well as cost effective patient management options. This platform was created from data collected from specific cancer patients over the past decade and will fill a critical informational need in cancer treatment.

Ascend's payer community consisting of health insurers, Third Party Administrators (TPA's) and self-funded employer groups, will have the ability to reduce cancer cost by integrating this shared decision-making platform for their patients and patients' healthcare providers. We estimate that a self-insured employer with 100,000 employees will save over $8M annually.

"We are thrilled to release this platform in collaboration with AscendPBM. Both of our organizations are focused on personalized approaches to healthcare that lead to improved outcomes and reduced cost for stakeholders. Together we will provide personalized information to patients and address the ever increasingly high-cost of cancer treatment," says Robert Palmer, CEO of PotentiaMetrics

"We're excited to integrate this tool (MyCancerJourney) into our innovative clinical platform to control the spiraling cost of oncology treatments and provide meaningful value to our clients. The analytical and AI healthcare solutions provided by PotentiaMetrics through the MyCancerJourney system is a one-of-a-kind platform and the first of many technological advances we are bringing to the healthcare ecosystem," said Ascend's CEO, Michael Ochoa.


About AscendPBM:

AscendPBM is a prescription benefit management organization that is disrupting the status quo by reducing healthcare cost using transparency, technology, appropriate utilization and improved patient outcomes.

To learn more about AscendPBM, visit:

About PotentiaMetrics:

PotentiaMetrics is an Austin, Texas, based healthcare data and artificial intelligence company that develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs.

To learn more about PotentiaMetrics, visit:        
To learn more about MyCancerJourney platform, visit:


SOURCE PotentiaMetrics

Editor Details

Last Updated: 27-Sep-2018